Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)
Clinical trial NCT07765212 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07765212
- Sponsor
- Eva M.M. Strijbis
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-09-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.